21 CFR Part 201 · Labeling

21 CFR 201.128

Meaning of “intended uses”

21 CFR 201.128 is the regulation titled “Meaning of ‘intended uses’” in 21 CFR Part 201, Labeling. Since 2021, 321 FDA warning letters have cited it.

Letters citing it
321 since 2021
Jan 1 to Oct 30, 2026
81 against 58 on the same dates in 2025
Most often cited with
21 CFR 211.22, in 60 letters
Closed out
1% of these letters have a published close-out
See the 321 letters citing 21 CFR 201.128 →

Letters citing it, by year issued

All are drug letters. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 602021
  2. 372022
  3. 132023
  4. 382024
  5. 922025
  6. 812026

What FDA writes when it cites it

The finding headings that cite 21 CFR 201.128 most often, as written in the letters.

  • 2 lettersYou failed to meet the conditions of sections 503A and 503B of the FD&C Act
  • 1 letter“Dissolve Mass (Stasis Breaker) helps dissipate nodules, palpable masses, and tumors by strongly invigorate [sic] the circulation of blood, qi, & lymph.”
  • 1 letter“Erectin Stimulating Gel is nicknamed the INSTANT ERECTION formula.”

The regulation

Read the text of 21 CFR 201.128 (eCFR, as of Sep 1, 2026)

The words intended uses or words of similar import in §§ 201.5, 201.115, 201.117, 201.119, 201.120, 201.122, and 1100.5 of this chapter refer to the objective intent of the persons legally responsible for the labeling of an article (or their representatives). The intent may be shown by such persons' expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article. This objective intent may, for example, be shown by labeling claims, advertising matter, or oral or written statements by such persons or their representatives. Objective intent may be shown, for example, by circumstances in which the article is, with the knowledge of such persons or their representatives, offered or used for a purpose for which it is neither labeled nor advertised; provided, however, that a firm would not be regarded as intending an unapproved new use for an approved drug based solely on that firm's knowledge that such drug was being prescribed or used by health care providers for such use. The intended uses of an article may change after it has been introduced into interstate commerce by its manufacturer. If, for example, a packer, distributor, or seller intends an article for different uses than those intended by the person from whom he or she received the article, such packer, distributor, or seller is required to supply adequate labeling in accordance with the new intended uses.

[86 FR 41401, Aug. 2, 2021]

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 201.128.

Latest letters citing it

The 3 letters citing 21 CFR 201.128 that FDA posted most recently.

See the 321 letters citing 21 CFR 201.128 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.